On March 24, 2026, Medtronic plc announced the FDA cleared its MiniMed Flex™ insulin pump, expected to boost revenue; however, projected earnings per share for FY 2026 were adjusted to $5.50-$5.54 from $5.62-$5.66 due to related costs.
AI Assistant
MEDTRONIC PLC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.